NeuroMetrix Reports Scientific Presentations at the American Academy of Pain Medicine 2020 Annual Meeting
25 févr. 2020 13h58 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Feb. 25, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present two scientific posters at the American Academy of Pain Medicine (AAPM) 36th...
NeuroMetrix Reports Q4 and Full Year 2019 Financial Results
27 janv. 2020 07h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Jan. 27, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and year ended December 31, 2019. The Company...
NeuroMetrix, Inc. 2019 Financial Conference Call Rescheduled to Monday January 27, 2020
22 janv. 2020 10h43 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Jan. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today announced the shift of its 2019 financial conference call to Monday, January 27, 2020 at 8:00am Eastern Time....
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2019 Financial Results Conference Call
17 janv. 2020 12h49 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Jan. 17, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 fourth quarter and full year financial results before the opening of...
NeuroMetrix Announces One-for-Ten Reverse Split
18 nov. 2019 11h50 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Nov. 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today announced the effectiveness of a one-for-ten reverse split of its common stock. The shares underlying the...
NeuroMetrix Reports Q3 2019 Financial Results
17 oct. 2019 07h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Oct. 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended September 30, 2019. The Company develops and...
NeuroMetrix Announces Updates to Quell 2.0 Commercial Strategy
15 oct. 2019 11h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes markets,...
NeuroMetrix, Inc. Announces Date for Third Quarter 2019 Financial Results Conference Call
10 oct. 2019 11h00 HE
|
NeuroMetrix, Inc.
WOBURN, Mass., Oct. 10, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 third quarter financial results before the opening of the market on...
NeuroMetrix Reports Q2 2019 Financial Results
18 juil. 2019 07h00 HE
|
NeuroMetrix, Inc.
WALTHAM, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2019. The Company develops and...
NeuroMetrix, Inc. Announces Date for Second Quarter 2019 Financial Results Conference Call
11 juil. 2019 13h15 HE
|
NeuroMetrix, Inc.
WALTHAM, Mass., July 11, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 second quarter financial results before the opening of the market on...